Concepedia

Montaser Shaheen

MS

Statistics

Publications

44

Citations

6.7K

H-Index

23

Active since

2003

Affiliations

University of Arizona(Current)

University of New Mexico

Huntsman Cancer Institute

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Montaser Shaheen is an author at University of Arizona specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2003–2024

44

Publications

44

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Michael A. Postow, Jason Chesney, Anna C. Pavlick et al. · New England Journal of Medicine · 2015 · 2.7K citations · Full text

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

F. Stephen Hodi, Jason Chesney, Anna C. Pavlick et al. · The Lancet Oncology · 2016 · 967 citations

, , +8

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 741 citations · Full text

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 598 citations

, , +7

Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining

Elizabeth A. Williamson, Leyma P. De Haro, Mark A. Brenneman et al. · Proceedings of the National Academy of Sciences · 2010 · 297 citations · Full text

, , +21

1–5 of 44